Creoptix and oneservice partner for WAVEsystem after-sales support
Wädenswil/Zurich, Switzerland, 25 November 2020 – Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, today announced that it has signed an agreement with oneservice AG, a global provider of specialty technical services, to offer after-sales support and services for its ground-breaking WAVEsystem in Europe and the US.Creoptix’ WAVEsystem is a label-free biosensor used in life sciences research to study molecular interactions in real-time. Based on proprietary Grating-Coupled Interferometry (GCI) technology, the Creoptix WAVEsystem offers a level of